In light of the prominent effect of the TGF‐β signalling pathway in tumourigenesis and other diseases, efforts have been made to target TGF‐β signalling in tumours, as well as its microenvironment for the development of chemotherapeutic agents.64, 100, 101, 102, 103, 104. Here, TGFB1 is linked to neoplasm.